OTCPK:MJNA

Stock Analysis Report

Executive Summary

Medical Marijuana, Inc., an investment holding company, operates in the medical marijuana and industrial hemp markets.

Snowflake

Fundamentals

Adequate balance sheet and overvalued.


Similar Companies

Share Price & News

How has Medical Marijuana's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MJNA's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

32.3%

MJNA

2.3%

US Healthcare

0.3%

US Market


1 Year Return

-60.4%

MJNA

-5.9%

US Healthcare

12.5%

US Market

Return vs Industry: MJNA underperformed the US Healthcare industry which returned -5.9% over the past year.

Return vs Market: MJNA underperformed the US Market which returned 12.5% over the past year.


Shareholder returns

MJNAIndustryMarket
7 Day32.3%2.3%0.3%
30 Day10.7%13.4%4.1%
90 Day-44.3%4.6%5.6%
1 Year-60.4%-60.4%-4.3%-5.9%15.0%12.5%
3 Year-76.8%-76.8%43.6%37.1%49.1%39.4%
5 Year-79.4%-79.4%61.7%50.6%62.8%44.7%

Price Volatility Vs. Market

How volatile is Medical Marijuana's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Medical Marijuana undervalued compared to its fair value and its price relative to the market?

1.6x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate MJNA's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate MJNA's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: MJNA is unprofitable, so we can't compare its PE Ratio to the Healthcare industry average.

PE vs Market: MJNA is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate MJNA's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: MJNA is good value based on its PB Ratio (1.6x) compared to the US Healthcare industry average (2.7x).


Next Steps

Future Growth

How is Medical Marijuana forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

14.2%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medical Marijuana has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Medical Marijuana performed over the past 5 years?

-48.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MJNA has large one-off items impacting its financial results.

Growing Profit Margin: MJNA's current net profit margins (-70.5%) are higher than last year (-674%).


Past Earnings Growth Analysis

Earnings Trend: MJNA is unprofitable, and losses have increased over the past 5 years at a rate of -48.2% per year.

Accelerating Growth: Unable to compare MJNA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MJNA is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (6.2%).


Return on Equity

High ROE: MJNA has a negative Return on Equity (-76.77%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Medical Marijuana's financial position?


Financial Position Analysis

Short Term Liabilities: MJNA's short term assets ($20.5M) exceeds its short term liabilities ($8.6M)

Long Term Liabilities: MJNA's short term assets (20.5M) exceeds its long term liabilities (13.5M)


Debt to Equity History and Analysis

Debt Level: MJNA's debt to equity ratio (19.8%) is considered satisfactory

Reducing Debt: MJNA's debt to equity ratio has reduced from 25.5% to 19.8% over the past 5 years.


Balance Sheet

Inventory Level: MJNA has a low level of unsold assets or inventory.

Debt Coverage by Assets: MJNA's debt is covered by short term assets (assets are 1.5x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MJNA has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: MJNA has less than a year of cash runway if free cash flow continues to reduce at historical rates of -7.1% each year


Next Steps

Dividend

What is Medical Marijuana's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.6%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate MJNA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate MJNA's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MJNA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MJNA's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MJNA's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Medical Marijuana's salary, the management and board of directors tenure and is there insider trading?

1.9yrs

Average management tenure


CEO

Stuart Titus 0

0yrs

Tenure

0

Dr. Stuart W. Titus, Ph.D., has been the Chief Executive Officer and President of Medical Marijuana, Inc. since March 18, 2015. Dr. Titus is the Chairman of the board of Director and Acting Chief Financial ...


Management Age and Tenure

1.9yrs

Average Tenure

Experienced Management: MJNA's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Board Age and Tenure

4.7yrs

Average Tenure

61yo

Average Age

Experienced Board: MJNA's board of directors are considered experienced (4.7 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.1%.


Management Team

  • George Anastassov (56yo)

    Member of Advisory Board and Chief Executive Officer of Canchew Biotechnologies

    • Tenure: 0yrs
  • Stuart Titus

    Chairman of the Board

    • Tenure: 0yrs
  • Chuck Smith

    Chief Operating Officer of Red Dice Holdings

    • Tenure: 0yrs
  • Blake Schroeder (41yo)

    COO & Executive VP

    • Tenure: 1.9yrs
  • Nicholas Massalas

    Director of Business Development

    • Tenure: 0yrs
  • Dirk Syburra

    Vice President of Data & Technology

    • Tenure: 2.8yrs
  • Raul Elizalde

    President of Latin America

    • Tenure: 1.8yrs
  • Tyler Whatcott

    Chief Technology Officer

    • Tenure: 0.08yrs

Board Members

  • Timothy Scott (66yo)

    Director

    • Tenure: 4.7yrs
  • Michelle Sides

    Director

    • Tenure: 8.2yrs
  • George Anastassov (56yo)

    Member of Advisory Board and Chief Executive Officer of Canchew Biotechnologies

    • Tenure: 0yrs
  • Philip Van Damme (66yo)

    Member of Advisory Board

    • Tenure: 0yrs
  • Lekhram Changoer (52yo)

    Member of Advisory Board

    • Tenure: 0yrs
  • Stuart Titus

    Chairman of the Board

    • Tenure: 0yrs
  • Bob Cunningham

    Director

    • Tenure: 4.7yrs
  • Chris Prine

    Director

    • Tenure: 4.7yrs

Company Information

Medical Marijuana, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Medical Marijuana, Inc.
  • Ticker: MJNA
  • Exchange: OTCPK
  • Founded: 2003
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$110.965m
  • Shares outstanding: 3.71b
  • Website: https://www.medicalmarijuanainc.com

Number of Employees


Location

  • Medical Marijuana, Inc.
  • 12255 Crosthwaite Circle
  • Poway
  • California
  • 92064
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MJNAOTCPK (Pink Sheets LLC)YesCommon StockUSUSDMar 2011

Biography

Medical Marijuana, Inc., an investment holding company, operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed an ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/11/12 00:20
End of Day Share Price2019/11/11 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.